| 百胜中国(YUMC US/9987 HK) - 业绩强劲收官，加盟转型，分红提升 | 黄铭谦 | 2026-02-05 |
| Alphabet (GOOGL US) - 全面发力 | 王腾杰,李怡珊,张贺楠 | 2026-02-05 |
| Yum China (YUMC US/9987 HK) - Strong finish, franchise pivot, higher payout | Wong Ming Him, Joseph | 2026-02-05 |
| Novartis (NVS US/NOVN SW) - Patent expiration fully priced in; late-stage pipeline reshapes the long-term growth curve | Chen Zhuhong, Jonah,Tan Zhen,Chen Hongdao, George | 2026-02-05 |
| Kuaishou (1024 HK) - Kling 3.0 launched, eC recommendation framework OneMall released | Li Yishan, Crystal,Wong Tang Kit, Tommy | 2026-02-05 |
| Alphabet (GOOGL US) - Firing on all cylinders | Wong Tang Kit, Tommy,Li Yishan, Crystal,Zhang Henan | 2026-02-05 |
| 轻松健康 (2661 HK) - AI驱动全链路健康闭环，战略转型开启高质量成长 | 陈泓道,陈铸鸿,谭震 | 2026-02-04 |
| QingSong Health (2661 HK) - AI-powered full-cycle health loop drives high-quality growth | Chen Hongdao, George,Chen Zhuhong, Jonah,Tan Zhen | 2026-02-04 |
| PONY AI (PONY US) - Investment gains narrow losses, scale-up and investment to accelerate in 2026 | Liang Yonghuo,Harrison, Yin Haocheng | 2026-02-04 |
| 教育行业 - 新东方与好未来业绩回顾：营收稳健；成本控制推动利润率超预期 | 李怡珊,王腾杰 | 2026-02-03 |
| Education Industry - EDU&TAL review: Top line solid; Margin beat driven by cost control | Li Yishan, Crystal,Wong Tang Kit, Tommy | 2026-02-03 |
| 港股市场周报 (2026/2/2) - 外部叙事加剧波动，港股配置如何稳中求进？ | 宁铂 | 2026-02-02 |
| HK Strategy Weekly (2 February 2026) - Overseas Narratives Heighten Volatility: How to Navigate Allocation with Resilience? | Ning Bo | 2026-02-02 |
| US Strategy Weekly (2 February 2026) - Could the Fed under Warsh's Leadership Reshape the Financial Market Order? | Ning Bo | 2026-02-02 |
| 美股市场周报(2026/2/2) - 沃什领导下的美联储能否重构金融市场秩序？ | 宁铂 | 2026-02-02 |
| Alphabet (GOOGL US); Roblox (RBLX US) - Gaming share price drops on Google’s Project Genie | Wong Tang Kit, Tommy,Li Yishan, Crystal,Zhang Henan | 2026-02-02 |
| 人形机器人 - 2026行业拐点：中国全产业链爆发，海外跨越式发展 | 梁勇活,殷浩程 | 2026-01-30 |
| Humanoid Robotics - 2026 Inflection point: Explosive expansion within China's industry chain, leapfrog development overseas | Liang Yonghuo,Harrison, Yin Haocheng | 2026-01-30 |
| CSPC Pharma (1093 HK) - Historical deal announced and why stock tumbled | Chen Zhuhong, Jonah,Tan Zhen,Chen Hongdao, George | 2026-01-30 |
| Laopu Gold (6181 HK) - From Gold Beta to Execution Risk | Wong Ming Him, Joseph | 2026-01-29 |